Croda International PLC to Discuss Acquisition with Iberchem and Propose Placing of Shares Call Transcript
Welcome to the Croda call. Shortly, I will hand over to your host, Steve Foots, Croda's Chief Executive. At the end of the presentation, there will be a Q&A session.
Steve, over to you.
Thank you, and morning, everybody. Yes. Here I am with Jez and Dave Bishop and we'll spend about 20 minutes going through the presentation and the rationale about Iberchem and why F&F and what we really want to do in this space and also plenty of time to ask questions along the way. So I'm going to try and rattle through the slide pack with Jez and then please build your questions up and then we'll -- as I said, we'll take that.
So putting this context on Slide 6. This is the grand plan. Part of the grand plan is to move Croda to more of a pure-play consumer ingredients business, and central to that is expanding our Life Science business. And you've seen with our Avanti acquisition and the connections with Pfizer that we're well on track there. We don't need
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
